| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
164 |
| issn |
1173-2563
1179-1918 |
| issueIdentifier |
3 |
| pageRange |
153-164 |
| publicationName |
Clinical Drug Investigation |
| startingPage |
153 |
| bibliographicCitation |
Scadding G. Predicting and establishing the clinical efficacy of a histamine h(1)-receptor antagonist : desloratadine, the model paradigm. Clin Drug Investig. 2005;25(3):153–64. doi: 10.2165/00044011-200525030-00001. PMID: 17523764. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2a97b51285de2eb5e45a9428284655d |
| date |
200503 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/17523764
https://doi.org/10.2165/00044011-200525030-00001 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33140
https://portal.issn.org/resource/ISSN/1179-1918
https://portal.issn.org/resource/ISSN/1173-2563 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Predicting and establishing the clinical efficacy of a histamine h(1)-receptor antagonist : desloratadine, the model paradigm |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124087
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6686
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_69c8365c5e015aa60518d03ac8157056
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9742
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fdf9e942b6ca454f8cceff3e4117f2c9 |